These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35779665)

  • 1. Drug Product Characterization of High Concentration Non-Aqueous Protein Powder Suspensions.
    Marschall C; Witt M; Hauptmeier B; Frieß W
    J Pharm Sci; 2023 Jan; 112(1):61-75. PubMed ID: 35779665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins.
    Marschall C; Witt M; Hauptmeier B; Friess W
    Eur J Pharm Biopharm; 2021 Apr; 161():37-49. PubMed ID: 33548460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating high-concentration monoclonal antibody powder suspension in nonaqueous suspension vehicles for subcutaneous injection.
    Bowen M; Armstrong N; Maa YF
    J Pharm Sci; 2012 Dec; 101(12):4433-43. PubMed ID: 23001898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of high concentration protein powder suspensions by milling of lyophilizates.
    Marschall C; Graf G; Witt M; Hauptmeier B; Friess W
    Eur J Pharm Biopharm; 2021 Sep; 166():75-86. PubMed ID: 34058328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical ocular protein delivery based on protein powder suspensions in semifluorinated alkanes.
    Marschall C; Filster J; Witt M; Hauptmeier B; Frieß W
    Eur J Pharm Biopharm; 2023 Aug; 189():233-239. PubMed ID: 37356639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection.
    Huang C; Chen L; Franzen L; Anderski J; Qian F
    Mol Pharm; 2022 May; 19(5):1505-1514. PubMed ID: 35417176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Pharm Res; 2015 May; 32(5):1694-703. PubMed ID: 25385690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions.
    Srinivasan C; Weight AK; Bussemer T; Klibanov AM
    Pharm Res; 2013 Jul; 30(7):1749-57. PubMed ID: 23543302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
    Allahham A; Stewart P; Marriott J; Mainwaring DE
    Int J Pharm; 2004 Feb; 270(1-2):139-48. PubMed ID: 14726130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oil-based suspension of a micro-environmental, pH-modifying solid dispersion for parenteral delivery: Formulation and stability evaluation.
    Zhang S; Wan Q; Xu X; Xing Y; Ding J; Yang S; Sun W; Lu M; Pan B
    Colloids Surf B Biointerfaces; 2019 Jul; 179():382-392. PubMed ID: 30999117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
    Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
    Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filling of High-Concentration Monoclonal Antibody Formulations: Investigating Underlying Mechanisms That Affect Precision of Low-Volume Fill by Peristaltic Pump.
    Shieu W; Lamar D; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2016; 70(2):143-56. PubMed ID: 26797970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and viscosity of a flavored omeprazole oral suspension for pediatric use.
    Burnett JE; Balkin ER
    Am J Health Syst Pharm; 2006 Nov; 63(22):2240-7. PubMed ID: 17090745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
    Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tretinoin photostability in a topical nanomedicine replacing original liquid suspension with spray-dried powder with no loss of effectiveness.
    Marchiori MC; Rascovetzki RH; Ourique AF; Rigo LA; Silva CB; Beck RC
    Drug Dev Ind Pharm; 2013 Apr; 39(4):579-86. PubMed ID: 22697376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody.
    Deokar V; Sharma A; Mody R; Volety SM
    J Pharm Sci; 2020 Dec; 109(12):3579-3589. PubMed ID: 32946895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral oil-based drospirenone microcrystal suspensions-evaluation of physicochemical stability and influence of stabilising agents.
    Nippe S; General S
    Int J Pharm; 2011 Sep; 416(1):181-8. PubMed ID: 21729745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
    Tewa-Tagne P; Briançon S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.